Jane Street’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Jane Street’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,314	Closed	-$920K	–	10520
2024 Q1	$920K	Sell	26,314 -11,632	-31%	-$424K	﹤0.01%	5570
2023 Q4	$1.44M	Sell	37,946 -4,369	-10%	-$93.6K	﹤0.01%	4894
2023 Q3	$776K	Sell	42,315 -1,736	-4%	-$36.3K	﹤0.01%	5554
2023 Q2	$1.14M	Sell	44,051 -39,834	-47%	-$930K	﹤0.01%	4999
2023 Q1	$1.58M	Buy	+83,885	New	+$1.95M	﹤0.01%	4217

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jane Street's INBX Position: Q2 2024 in Review

Jane Street sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 26,314 shares — an estimated $920K sold.

Jane Street first reported a position in INBX in Q1 2023 and held it in 5 quarters. The position peaked at $1.58M in Q1 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Jane Street reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Jane Street sold 26,314 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $920K.
Jane Street first reported a position in Inhibrx, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
Jane Street's Inhibrx, Inc. Common Stock position peaked at $1.58M in Q1 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.